arrow
L

Leanna Troncoso

Tisch Cancer Institute
H指数:10
被引数:2,192

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dendritic cells control tertiary lymphoid structure development and maintenance in cancer

树突状细胞调控肿瘤中三级淋巴样结构的发育与维持

Science
IF45.8
2026-07-160
PRE
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade

对肿瘤抗原的体液IgG1反应是免疫检查点阻断的临床结果的基础

2026-01-270
OAAI
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours

髓系祖细胞失调促进肿瘤中的免疫抑制性巨噬细胞

Nature
IF48.5
2025-09-100
PRE
Multiparametric cellular and spatial organization in cancer tissue lesions with a streamlined pipeline

癌症组织病变中的多参数细胞和空间组织及其简化流程

2025-08-250
OAAI
Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis

造血衰老通过促进IL-1驱动的紧急骨髓生成而促进癌症

Science
IF45.8
2024-01-010
OA
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Nature
IF48.5
2023-12-060
PRE
Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders
IMMUNITY
IF26.3
2023-12-0111
OAAI
Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

肝癌PD-1阻断后,肿瘤内树突状cell-CD4 T辅助细胞壁ni使CD8 T细胞分化

2023-06-15107
PRE
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer

TREM2巨噬细胞驱动肺癌中NK细胞的缺乏和功能障碍

2023-04-2066
PRE
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

cemiplimab新辅助治疗可切除肝细胞癌: 一项单臂、开放标签、2期试验

2022-03-01121
OAAI